Mirae Asset Global Investments Co. Ltd. Acquires 14,108 Shares of Danaher Corporation $DHR

Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Danaher Corporation (NYSE:DHR) by 13.5% in the 3rd quarter, HoldingsChannel reports. The firm owned 118,604 shares of the conglomerate’s stock after buying an additional 14,108 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Danaher were worth $23,514,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. White Pine Capital LLC lifted its stake in shares of Danaher by 1.4% during the 2nd quarter. White Pine Capital LLC now owns 3,494 shares of the conglomerate’s stock worth $690,000 after buying an additional 49 shares during the last quarter. SOL Capital Management CO raised its holdings in Danaher by 2.8% in the 3rd quarter. SOL Capital Management CO now owns 1,829 shares of the conglomerate’s stock valued at $363,000 after acquiring an additional 50 shares during the period. Purkiss Capital Advisors LLC raised its holdings in Danaher by 3.9% in the 3rd quarter. Purkiss Capital Advisors LLC now owns 1,327 shares of the conglomerate’s stock valued at $263,000 after acquiring an additional 50 shares during the period. Boyd Watterson Asset Management LLC OH lifted its position in Danaher by 2.1% during the second quarter. Boyd Watterson Asset Management LLC OH now owns 2,524 shares of the conglomerate’s stock worth $499,000 after acquiring an additional 51 shares during the last quarter. Finally, Howard Capital Management Group LLC boosted its holdings in shares of Danaher by 4.8% during the third quarter. Howard Capital Management Group LLC now owns 1,159 shares of the conglomerate’s stock worth $230,000 after acquiring an additional 53 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on DHR shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Danaher in a research note on Monday, December 29th. HSBC increased their price objective on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Wells Fargo & Company boosted their target price on shares of Danaher from $230.00 to $240.00 and gave the company an “equal weight” rating in a research report on Monday, December 15th. Argus set a $265.00 price target on shares of Danaher in a research note on Wednesday, January 14th. Finally, Robert W. Baird set a $251.00 price objective on shares of Danaher in a research note on Thursday. Twenty research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and an average target price of $252.55.

Danaher Stock Performance

DHR opened at $219.62 on Friday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.10 and a current ratio of 1.87. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $242.80. The firm has a market cap of $155.13 billion, a P/E ratio of 43.58, a price-to-earnings-growth ratio of 3.42 and a beta of 0.89. The business’s fifty day moving average is $230.77 and its 200-day moving average is $213.81.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 28th. The conglomerate reported $2.23 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. Danaher’s revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.14 earnings per share. Danaher has set its FY 2026 guidance at 8.350-8.500 EPS. Sell-side analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be given a dividend of $0.32 per share. The ex-dividend date is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is currently 26.39%.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 3,298 shares of the business’s stock in a transaction that occurred on Tuesday, November 18th. The shares were sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director directly owned 20,762 shares in the company, valued at $4,702,593. The trade was a 13.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, SVP Georgeann Couchara sold 5,174 shares of the company’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president owned 2,625 shares of the company’s stock, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 30,248 shares of company stock valued at $6,609,663 over the last three months. 11.10% of the stock is owned by insiders.

Key Stories Impacting Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher beat Q4 consensus — reported $2.23 EPS vs. ~$2.14 expected and revenue $6.84B topping estimates, showing growth across Life Sciences, Diagnostics and Bioprocessing. PR Newswire: Q4 Results
• Positive Sentiment: Analyst support: JPMorgan raised its price target to $275 and kept an Overweight rating, highlighting upside vs. current levels and supporting longer‑term conviction. Benzinga: JPMorgan PT Raise
• Neutral Sentiment: FY‑2026 EPS guidance of $8.35–$8.50 was issued and sits essentially inline with the Street (~$8.42), so the outlook is credible but not a positive catalyst above expectations. Reuters: 2026 Forecast
• Neutral Sentiment: Management highlighted strong free cash flow and balance‑sheet strength, which supports buybacks/dividends and long‑term investment in bioprocessing but is not a near‑term growth surprise. TipRanks: Cash Strength
• Negative Sentiment: Market reaction: shares fell after the print as investors parsed the in‑line guidance and cautious commentary on end‑market recovery, leading to short‑term selling despite the beat. Seeking Alpha: Stock Drops
• Negative Sentiment: Commentary emphasized a gradual (not rapid) recovery in pharma spending and continued weakness in some academic research markets — investors looking for a stronger acceleration may have reduced exposure. Benzinga: Gradual Improvement

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.